Cold atmospheric plasma technology, currently the only way to remove microscopic cancer tumors remaining from surgery, has been approved by the U.S. Food and Drug Administration for first-ever use in ...
Cold atmospheric plasma technology, currently the only way to remove microscopic cancer tumors remaining from surgery, has been approved by the U.S. Food and Drug Administration for first-ever use in ...
TAKOMA PARK, Md.--(BUSINESS WIRE)--US Medical Innovations, LLC (USMI), a Biomedical and Life Science subsidiary of US Patent Innovations, LLC and the Jerome Canady Research Institute for Advanced ...
Respiratory viral infections, including COVID-19 and severe acute respiratory syndrome (SARS), are primarily transmitted through aerosolized droplets that carry infectious viral particles within the ...
WEST LAFAYETTE, Ind. — Cold atmospheric plasma technology, currently the only way to remove microscopic cancer tumors remaining from surgery, has been approved by the U.S. Food and Drug Administration ...
TAKOMA PARK, Md.--(BUSINESS WIRE)--US Medical Innovations, LLC (USMI) announced today it has received FDA 510k Clearance (K240297) for the Canady Helios Cold Plasma™ (CHCP) Ablation System for the ...
Based on industry, the plastic & polymer industry registered the highest share in cold plasma market, the demand for the use of cold plasma in the plastic and polymer industries is rising ...